Compound Detail
CHEMBL510964
LEUCOPAXILLONE A Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(=O)O[C@H](C[C@@H](OC(C)=O)C(C)(C)O)[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CCC(=O)C4(C)C)[C@]3(C)CC[C@]12CO
Basic Information
| ChEMBL ID | CHEMBL510964 |
| Name | LEUCOPAXILLONE A |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VNEQIRWUIXRANF-NUXCKAEHSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
574.8
MW (Da)
5.79
ALogP
7
HBA
2
HBD
110.1
PSA (Ų)
0.28
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 5.1
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MCF7 | IC50 | = | 7940.0 | nM | 5.1 | Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay | 15568769 |
| HepG2 | IC50 | = | 96700.0 | nM | 4.01 | Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay | 15568769 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15568769 | 10.1021/np049883o | A549 | 1 |
| 15568769 | 10.1021/np049883o | CAKI-1 | 1 |
| 15568769 | 10.1021/np049883o | HepG2 | 1 |
| 15568769 | 10.1021/np049883o | MCF7 | 1 |
| 17190463 | 10.1021/np060213n | NCI-H460 | 1 |
Data from ChEMBL 36 via Core Engine